Patent · US Active

Microorganisms programmed to produce immune modulators and anti-cancer therapeutics in tumor cells

US11471494B2 · kind B2 · utility

6Cited by

1References

10Claims

0Family size

Assignee

Synlogic Operating Company, Inc. · US

Inventors

Dean Falb · Sherborn, US
Jonathan W. Kotula · Somerville, US
Vincent M. Isabella · Medford, US
Paul F. Miller · Salem, US
Suman Machinani · Cambridge, US
Saurabh Saha · Wellesley, US
Adam B. Fisher · Cambridge, US
Yves Millet · Newton, US
Ning Li · New Canaan, US
Jose M. Lora · Arlington, US

Key dates

Filing date	Jan 5, 2018
Grant date	Oct 18, 2022
Priority date	—
Expiry date	Apr 5, 2039

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Genetically programmed microorganisms, such as bacteria or virus, pharmaceutical compositions thereof, and methods of modulating and treating cancers are disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.